EBS · Emergent BioSolutions Inc. · Documents

$6.12 -0.08 (-1.29%)

Market Cap

$317.89M

51.27M

Volume · Oct 21 851.82K Avg daily vol (3M) 1.19M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
8-K	—	2021-07-22	2021-07-20
8-K	—	2021-07-14	2021-07-13
8-K	—	2021-05-25	2021-05-20
8-K	—	2021-05-12	—
10-Q	—	2021-04-30	2021-03-31
8-K	—	2021-04-29	—
8-K	—	2021-04-21	—
8-K	—	2021-04-19	—
DEFA14A	—	2021-04-09	—
DEF 14A	—	2021-04-09	—
8-K	—	2021-04-05	2021-04-04
8-K	—	2021-04-01	—
10-K	—	2021-02-19	2020-12-31
8-K	—	2021-02-18	—
8-K	—	2021-02-16	2021-02-09
8-K	—	2021-01-11	2021-01-10
10-Q	—	2020-11-06	2020-09-30
8-K	—	2020-11-05	—
8-K	—	2020-08-26	2020-08-25
8-K	—	2020-08-07	2020-08-04
8-K	—	2020-08-05	2020-08-04
8-K	—	2020-07-31	2020-07-30
10-Q	—	2020-07-31	2020-06-30
8-K	—	2020-07-27	2020-07-26
8-K	—	2020-07-14	2020-07-13
8-K	—	2020-07-06	2020-07-02
8-K	—	2020-06-11	—
8-K	—	2020-06-08	2020-06-05
8-K	—	2020-06-01	2020-05-30
8-K	—	2020-05-28	—
8-K	—	2020-05-27	2020-05-26
8-K	—	2020-05-08	—
10-Q	—	2020-05-01	2020-03-31
8-K/A	—	2020-05-01	2020-04-30
8-K	—	2020-04-30	—
8-K	—	2020-04-24	2020-04-23
DEFA14A	—	2020-04-09	—
DEF 14A	—	2020-04-09	2020-05-21
10-K	—	2020-02-25	2019-12-31
8-K	—	2020-02-20	—
8-K	—	2020-02-18	2020-02-11
8-K	—	2020-01-13	—

Showing 151–192 of 192 filings

Key facts CIK 1367644 CUSIP 29089Q105 13F (30d) 22 filings 22 filers Visit website Investor relations